Mirvetuximab soravtansine-gynx waxa ay USFDA u ansixisay FRα positive, platinum u adkaysta epithelial ugxansidaha, tuubada fallopian, ama kansarka mindhicirka aasaasiga ah
March 2024: The Food and Drug Administration has granted approval for mirvetuximab soravtansine-gynx (Elahere, ImmunoGen, Inc. [now a part of AbbVie]) to be used in adult patients with FRα positive, platinum-resistant epithelial ..
Tijaabooyinka caafimaadka
Daaweynta Unugyada MESO-CAR T ee soo noqoshada iyo dib u soo celinta Kansarka Epithelial Ovarian
March 2023: Brief Summary: The purpose of this clinical trial is to find out if anti-MESO antigen receptor CAR T-cell therapy can be used to treat epithelial ovarian cancer that has come back or stopped responding to other..
mirvetuximab soravtansine-gyn
Mirvetuximab soravtansine-gynx waxaa la siiyay ogolaansho degdeg ah oo loogu talagalay FRα positive, platinum u adkaysta epithelial ugxansidaha, tuubada fallopian, ama kansarka peritoneal
Noofembar 2022: Bukaannada qaangaarka ah ee lahaa hal ilaa saddex hab oo daawaynta habaysan oo hore oo leh folate receptor alpha (FR) togan, ugxan-sidaha epithelial ee platinum-u adkaysta, tuubada ugxan-sidaha, ama kansarka mindhicirka hoose, F..
Lancet, Mekist, tamoxin, Trametinib
Daawaynta cusub ee loo aqoonsaday darajo hoose iyo kansarka ugxansidaha daran
Maajo 2022: Trametinib waxa laga yaabaa inay noqoto heer cusub oo daryeel loogu talagalay soo noqnoqda, kansarka ugxan-sidaha (Mekinist). Marka loo eego natiijooyinka daraasadda ee lagu daabacay daabacaadda Febraayo 2022 ee Lancet, trametinib waxay garaacday labadaba daaweynta kiimikaad ...
Cytalux, NCT03180307, pafolacinine, Shaybaadhka Bartilmaameedka
Pafolacianine ayaa loo oggolaaday in lagu aqoonsado nabarrada kansarka ugxan-sidaha ee xun
Jan 2022: Pafolacianine (Cytalux, On Target Laboratories, LLC), wakiilka sawirka indhaha, waxa shati ka siisay Maamulka Cuntada iyo Dawooyinka bukaanada qaangaarka ah ee qaba kansarka ugxansidaha iyada oo caawiye u ah ogaanshaha isdhexgalka ee
Niraparib
Niraparib wuxuu ku guuleystaa natiijooyin la yaab leh ugxansidaha iyo kansarka naasaha
Kansarka naasaha iyo ugxansidaha Haddii aad tahay bukaanka kansarka naasaha iyo ugxansidaha, waxaa dhacda inaad ogaato inaad tahay kansar ku dhaca isbeddelka BRCA1 / 2 kadib markaad ka gudubto baaritaanka hidda-socodka, noloshaadana la badbaadiyo. Sida laga soo xigtay Global Oncolog ..
Acalabrutunib, Avelumab, Daaweynta CART, Dabrafanib, Kymiah, Dawooyinka ugu dambeeyay, Midostaurin, Niraparib, Pembrolizumab, Tecartus, Tisagenlecleucel, Trametinib, USFDA
Daawooyinka ugu dambeeyay ee daaweynta kansarka
July 2021: Check out the latest drugs in the treatment of cancer. Every year, after examining the trials and other important factors, the USFDA approves drugs, and thus cancer patients can now believe that a cure is very near. ..